An str gene cluster containing at least four genes (strR, strA, strB, and strC) involved in streptomycin biosynthesis or streptomycin resistance or both was self-cloned in Streptomyces griseus by using plasmid pOA154. The strA gene was verified to encode streptomycin 6-phosphotransferase, a streptomycin resistance factor in S. griseus, by examining the gene product expressed in Escherichia coli. The other three genes were determined by complementation tests with streptomycin-nonproducing mutants whose biochemical lesions were clearly identified. strR complemented streptomycin-sensitive mutant SM196 which exhibited impaired activity of both steptomycin 6-phosphotransferase and amidinotransferase (one of the streptomycin biosynthetic enzymes) due to a regulatory mutation; strB complemented strain SD141, which was specifically deficient in amidinotransferase; and strC complemented strain SD245, which was deficient in linkage between streptidine 6-phosphate and dihydrostreptose. By deletion analysis of plasmids with appropriate restriction endonucleases, the order of the four genes was determined to be strR-strA-strB-strC. Transformation of S. griseus with plasmids carrying both strR and strB genes enhanced amidinotransferase activity in the transformed cells. Based on the gene dosage effect and the biological characteristics of the mutants complemented by strR and strB, it was concluded that strB encodes amidinotransferase and strR encodes a positive effector required for the full expression of strA and strB genes. Furthermore, it was found that amplification of a specific 0.7-kilobase region of the cloned DNA on a plasmid inhibited streptomycin biosynthesis of the transformants. This DNA region might contain a regulatory apparatus that participates in the control of streptomycin biosynthesis.
Streptomycin, N-methyl-a-L-glucosamine(1"-t2')-a-Lstreptose(1'->4)streptidine, is produced by certain strains of Steptomyces spp. In batch cultures, streptomycin is accumulated only after cell growth has virtually ceased; this type of nongrowth association is a well-known feature of antibiotic synthesis (5, 19) . A majority of the enzymatic reactions dedicated to streptomycin biosynthesis have been identified through extensive studies by a number of investigators (11, 12, 16, 34, 35; Fig. 1 ). The activities of these streptomycinbiosynthetic enzymes are coordinately expressed just before the onset of streptomycin accumulation (35) .
In addition to the biosynthetic enzymes, the streptomycinproducing strains synthesize streptomycin 6-phosphotransferase, which catalyzes the reaction step N in Fig. 1 , to protect themselves from the suicidal action of the drug (24, 31) . Streptomycin 6-phosphotransferase activity appears together with the streptomycin-biosynthetic enzymes and increases in parallel with streptomycin accumulation (24) .
Cloning of the str genes involved in streptomycin biosynthesis and streptomycin resistance would provide an approach to understanding their genetic structure and the regulatory mechanisms. We have already developed a hostvector system in Steptomyces griseus ATCC 10137, a streptomycin producer (21, 23) , and have isolated a series of well-characterized streptomycin-nonproducing mutants (22) . In this report we describe the cloning and analysis of four contiguous str genes, including a regulatory gene, by using these mutants as recipients.
MATERIALS AND METHODS
Bacterial strains and plasmids. S. griseus strains used in this study are listed in Table 1 . pOA154 (13.7 kilobases [kb]), carrying a tetracycline resistance gene of Streptomyces rimosus (23) , was used as a vector plasmid in S. griseus. The copy number of pOA154 was assessed to be about 20 copies per chromosome by referring to the copy number of its parental plasmid, pOA15 (21) . For the construction of recombinant plasmids in Escherichia coli, E. coli C600-1 (10) and pBR322 (3) were used.
Bacillus subtilis ATCC 6633 and B. subtilis MI113 harboring pTB90 (which confers tetracycline resistance to the host) (9) were used as indicator bacteria in the bioassay of streptomycin.
Media. Nutrient agar and antibiotic medium no. 5 were purchased from Difco Laboratories, Detroit, Mich. Trypticase soy broth was from BBL Microbiology Systems, Cockeysville, Md. Glycerol-asparagine medium (28) , GMP medium (6), R2YE medium (4) , and LB medium (20) have been described previously.
Preparation of plasmid and chromosomal DNA. For the isolation of Streptomyces plasmids, S. griseus strains harboring plasmids were grown in Trypticase soy broth containing 0.8% glycine and 20 ,ug of tetracycline per ml, and the rapid alkaline extraction method was performed as described previously (23) . Chromosomal DNA of S. griseus was isolated by lysozyme-pronase-RNase treatment and phenol extraction as described elsewhere (23) . E. coli plasmids were isolated by the modified alkaline lysis method after chloramphenicol amplification (18 (11, 12, 16, 34, 35) . Compounds: 1, myo-inositol; 2, scyllo-inosose; 3, scyllo-inosamine; 4, scyllo-inosamine 4-phosphate; 5, amidino-scyllo-inosamine 4-phosphate; 6, amidino-scyllo-inosamine; 7, amidino-3-keto-scyllo-inosamine; 8, amidinostreptamine; 9, amidinostreptamine 6-phosphate; 10, streptidine 6-phosphate; 11, dTDP-L-dihydrostreptose; 12, 0-a-Ldihydrostreptose(l'-+'4)streptidine 6-phosphate; 13 Fig. 1 ). The two steps of transamination (B, G), phosphorylation (C, H), and transamidination (D, I) seem to be catalyzed by single enzymes, respectively (22 (20 ,ug/ml) was added to the medium to ensure stable maintenance of the plasmid. Mycelia were harvested by filtration and washed with distilled water. To the washed pad (0.5 to 1.0 g) was added 1.5 ml of distilled water, and cell extracts were prepared by sonication (33) . For the preparation of cell extracts of E. coli strains, cells grown to an optical density at 550 nm of about 1.0 in 100 ml of LB medium supplemented with appropriate antibiotics were centrifuged, suspended in 1 ml of distilled water, and sonicated.
Assays of streptomycin-inactivating activity and streptomycin 6-phosphotransferase activity were carried out essentially as described by Piwowarski and Shaw (24) . The reaction mixture for the inactivation of streptomycin consisted of 50 10 pul of the reaction mixture was subjected to paper chromatography with a solvent system of 80% (vol/vol) phenol and an NH3 atmosphere for the separation of reaction products (33) . The paper strips were cut at 1-cm intervals, and radioactivity was counted with a liquid scintillation system. One unit of streptomycin 6-phosphotransferase is defined as the amount that catalyzes the formation of 1 nmol of streptidine 6-phosphate per h at 30°C.
For assay of amidinotransferase activity, tratisamidination from L-arginine to hydroxylamine, yielding hydroxyguanidine, was measured by the method of Walker (33) . This assay works well with enzyme(s)-catalyzing reaction steps D and I in Fig. 1 (33 The dialyzed sample was loaded onto a DEAE-cellulose column (3.2 by 62 cm). Initially, 1 liter of 20 mM phosphate buffer was passed, and the activity was eluted with 500 ml of 0.3 M NaCl in 20 mM phosphate buffer. Active fractions were pooled and precipitated with ammonium sulfate (70% of saturation). After dialysis against 50 mM phosphate buffer, the sample was loaded onto a Sephadex G-100 column New England Nuclear Co., Boston, Mass.; AatI (an isoschizomer of Stul) was from Toyobo Biochemicals, Osaka, Japan; restriction endonucleases other than AatI, T4 DNA ligase, T4 polynucleotide kinase, and BglII octanucleotide linkers were from Takara Shuzo Co. Ltd., Kyoto, Japan; marker proteins for SDS-gel electrophoresis and gel filtration were from Boehringer GmbH, Mannheim, Federal Republic of Germany; Sephadex G-100 and G.200 were from Pharmacia Fine Chemicals, Uppsala, Sweden; DEAEcellulose was from Wako Chemnical Industries, Osaka, Japan; DEAE-Toyopearl 650M was from Toyo Soda Co., Tokyo, Japan. The sources of other reagents have been described previously (22, 23) .
RESULTS
Characterization of a streptomycin-nonproducing, streptomycin-sensitive mutant. Str-strains with clearly defined mutations would be useful as host cells for the cloning of str genes. Nine Str-mutants used in this study were derived from S. griseus ATCC 10137 by UV irradiation. Eight mutants (SD20, SD81, SD141, SD189, SD245, SD261, SD263, and SD274) were streptidine idiotrophs which required streptidine to produce streptomycin, and their biochemical lesions in the biosynthetic pathway to streptomycin are shown in Table 1 (22) . An Strs mutant, SM196, was selected among Str-mutants that retained the ability to Simultaneous loss of the capability to produce streptomycin and streptomycin resistance inferred a possibility that SM196 might be deficient in biosynthesis of an autoregulating factor, A-factor (2S-isocapryloyl-3S-hydroxymethyl--ybutyrolactone), which is essential for streptomycin synthesis, streptomycin resistance, and spore formation in S. griseus (6) . However, A-factor secreted from a colony of the wild type could restore the capability of producing streptomycin to putative A-factor-defective mutahts (characterized as Str-, asporogenic mutants in a previous study [22] ) but not to SM196. This, and the ability of SM196 to sporulate, make it unlikely that SM196 is A-factor defective.
It has been reported that streptomycin resistance in streptomycin-producing Streptomyces spp. is mediated by inactivation of the drug with streptomycin 6-phosphotransferase (24, 31) . Assays of streptomycin 6-phosphotransferase activity were carried out with cell extracts from stationary-phase GMP cultures of the wild-type, SM196, and SD141 strains ( 4 . Restriction endonuclease cleavage m4p of pADT4 and the construction of its derivatives in S. griseus. Heavy lines indicate the DNA inserts derived from the cloned DNA of pADT4. Symbols for the restriction sites are as shown in the restriction map of pADT4. The 7.4-kb PglII fragment of pADT4 was purified by low-melting-temperature agarose gel electrophoresis and ligated with BamHI-digested pOA154, resulting in pADT41 and pADT42. pADT43, pADT44, pADT45, and pADT46 were constructed by partial digestion of the purified 7.4-kb fragment with BamHI, followed by ligation with BamHI-digested pOA154 at a low DNA concentration (about 5 ,ug/ml). pADT411, pADT412, and pADT413 were constructed by digestion of pADT41 with the indicated restriction endonucleases, followed by religation of the mixtures. pADT4A4 was obtained by an in vivo deletion of about 9.4 kb of DNA encompassing the vector and cloned DNA regions of pADT4.
electrophoresis. We did not observe multiple activities of amidinotransferase during enzyme purification and thus conclude that the single amidinotransferase catalyzed both transamidination steps (steps D and I in Fig. 1 ) in streptomycin biosynthesis. The final preparation had a specific activity of 11.5 U per mg of protein, which corresponded to about a 70-fold purification from the crude cell extract and a final recovery of about 5%. The apparent molecular weight of the purified amidinotransferase was about 42,000, as determined by SDS-polyacrylamide gel electrophoresis. On Sephadex G-200 gel filtration, the enzyme was eluted at the fraction corresponding to an estimated molecular weight of about 50,000 (data not shown). Hence, the amidinotransferase of S. griseus ATCC 10137 appeared to be a monomer.
Cloning of str genes. Antibiotic production genes are often clustered (8, 17, 25) . Our strategy for cloning str genes was to search for a DNA segment capable of complementing the amidinotransferase-deficient mutant SD141 and then to examine the capacity of cloned DNA to complement the other Str-mutants.
The chromosomal DNA (10 ,ug) of S. griseus ATCC 10137 was partially digested with Sau3A into fragments of about 2 to 25 kb in length and mixed with pOA154 (1.0 ,ug) treated with BamHI and thereafter with bacterial alkaline phosphatase. After phenol extraction and ethanol precipitation, the DNA sample was ligated with T4 DNA ligase in 100 ,ul of ligation buffer. The ligated DNA was used to transform 4 x 109 protoplasts of SD141. After regeneration of protoplasts and sporulation, spores were replica plated onto nutrient agar containing tetracycline. About 16,000 primary transformants could grow on the plates.
When overlaid with antibiotic medium no. 5 containing spores of B. subtilis(pTB90), six clones exhibited an inhibitory zone against the B. subtilis strain. Plasmids purified from the six clones were used to transform SD141 again. In all cases, most of the tetracycline-resistant transformants produced antibiotics. Therefore, it was concluded that some genes conferring the ability to synthesize an antibiotic on SD141 were cloned into these recombinant plasmids, which were named as pADT1 to pADT6, respectively. For example, Fig. 3 demonstrates that SD141 recovered the ability to produce an antibiotic when transformed with pADT4.
The restriction endonuclease cleavage maps of these plasmids were constructed (pADT4 is shown in Fig. 4 ; the maps of the other plasmids are not shown). pADT1, pADT2, pADT3, pADT4, pADT5, and pADT6 had DNA inserts of 14, 2.8, 6.2, 10, 9.0, and 5.4 kb, respectively. As far as their cleavage maps were concerned, none of the DNA inserts shared a common DNA region. The activity of amidinotransferase synthesized by the SD141 strains carrying each of the six plasmids was determined by using crude extracts of liquid-grown cultures as the enzyme source. Only in the clone carrying pADT4 was the activity detected, whereas the remaining clones did not contain a detectable amount of the activity, as observed in SD141. This finding means that the antibiotic produced by the clone carrying pADT4 was streptomycin and that the antibiotics produced by the other clones were not streptomycin. Therefore, further investigation was focused exclusively on pADT4.
To examine whether the cloned DNA carried some other streptomycin biosynthesis genes, pADT4 was introduced by transformation into the other streptidine-idiotrophic mutants (SD20, SD81, SD189, SD245, SD261, SD263, and SD274) and the Str-Strs mutant (SM196). Tetracycline-resistant transformants of SD245 and SM196 gave rise to an inhibitory zone against B. subtilis(pTB90), whereas those of the other mutants did not. This result suggests that pADT4 encodes genes that complement SD245 and SM196 as well as SD141.
Southern analysis of BglII-digested total DNA samples of S. griseus ATCC 10137, SD141, SD245, and SM196, using pSMP1 (constructed by subcloning the 7.4-kb Bglll fragment of pADT4 into a unique Scal site of pBR322 [ Fig. 5]) as a probe, showed hybridization solely to a 7.4-kb band in every case (data not shown). Therefore, at least for this 7.4-kb fragment, there are no major deletions or rearrangements in the cloned DNA or in the three mutants.
Subcloning of str genes. The cloned genes that complemented SD141, SD245, and SM196 were designated strB, strC, and strR, respectively; strA was for a structural gene of streptomycin 6-phosphotransferase (see below). To localize these str genes on the cloned DNA and also to assess the effect of amplification of each str gene on streptomycin productivity, amidinotransferase activity, and streptomycin 6-phosphotransferase activity, we subcloned various segments of the cloned str DNA into the BamHI site of pOA154 (Fig. 4) . The resulting derivative plasmids and a spontaneously deleted pADT4 derivative pADT4A4 (Fig. 4) were introduced by transformation into strains SD141, SD245, and SM196 as well as into the wild-type strain (ATCC 10137). Streptomycin productivities of the transformants were estimated by the agar-plug method as exemplified in Fig. 3 , and activities of amidinotransferase and streptomycin 6-phosphotransferase were assayed (Table 3 and Fig. 6 ).
The strB+ plasmids that complemented SD141 were pADT41, pADT42, pADT413, pADT43, and pADT4A4, which shared a common region from the left end of the insert of pADT4A4 to the BgIII(2) site (Fig. 6 ) (restriction sites appearing more than once on the DNA insert are distinguished by the numbers in paretheses). The molecular size of the strB region was about 3.0 kb, which is large enough to encode amidinotransferase (molecular weight, about 42,000). Neither pADT45 nor pADT46 could confer the ability to synthesize amidinotransferase on SD141, suggesting that the BamHI(4) site is located in an essential region of the strB gene. Only pADT4 and pADT4A4 conferred the ability to produce streptomycin (Str+ phenotype) on SD245, indicating that part or all of strC is to the right of the BglII (2) site (Fig. 6) . pADT41, pADT42, pADT411, and pADT412 could transform SM196 for the Str+ phenotype (Table 3) . It was confirmed by enzyme assays that these strR+ plasmids restored the ability of SM196 to synthesize both amidinotransferase and streptomycin 6-phosphotransferase (Table 3). The strR region spanned the restriction fragment (about 3.3 kb) from BglII(1) to BamHI (1) (Fig. 6) .
Since the recovery of the pleiotropic defects in SM196 by strR implied that strR might be a regulatory gene, it was important to determine whether strR encoded a gene product. SM196 carrying pADT412 (strR+ strA strB strC) (see below for strA of the plasmid) was grown on nutrient agar without tetracycline, and after sporulation spores were suspended in distilled water and plated on nutrient agar. A total of 30 tetracycline-sensitive segregants (obtained at a frequency of 30%) were Str-. This result indicates that restoration of the Str' phenotype to SM196 with pADT412 does not require homologous recombination between the cloned DNA on the plasmid and the chromosome of the mutant. Therefore, we conclude that the strR gene encodes a transacting substance.
The transformants harboring either pADT41 or pADT42, irrespective of the host strains, expressed much more (threeto sixfold) amidinotransferase activity than the wild-type strain (Table 3 ). This result suggests that a structural gene of Fig. 4 . The details of the procedures for plasmid constructions are given in the text. Boundaries of the deletion (indicated by a thin line inside the map of pSMP2) and the inversion (indicated inside the map of pSMP3) were roughly estimated; an EcoRV site on pSMP21 and pSMP31 was mapped at the same position as on pBR322, i.e., about 0.2 kb apart counterclockwise from the BamHI site of pBR322.
amidinotransferase is carried on the 7.4-kb BglII fragment. However, none of the other plasmids enhanced the expression of amidinotransferase activity in S. griseus ATCC 10137 even if they carried either strR or strB; pADT411 and pADT412 were strR+ strB plasmids, whereas pADT413 was a strR strB+ plasmid (Table 3) . Streptomycin 6-phosphotransferase activity was slightly enhanced in SM196 carrying pADT41 or pADT42, but not for SM196 carrying any other plasmids (Table 3) .
Streptomycin productivity of S. griseus ATCC 10137 was increased five-to sevenfold by transformation with each of pADT41, pADT42, pADT411, and pADT412 (Table 3 ). The DNA region responsible for the enhancement of streptomycin production ranged from BglII(1) to BamHI(l), in which the strR gene was coded (Fig. 6) .
We unexpectedly discovered that pADT43 and pADT44 markedly inhibited streptomycin production of S. griseus ATCC 10137 (Table 3 ). In addition, pADT43 and pADT44 were found to impair activities of both amidinotransferase and streptomycin 6-phosphotransferase (Table 3) . Tetracycline-sensitive segregants were derived from S. griseus ATCC 10137(pADT44) by cultivation on nutrient agar without tetracycline. All the segregants (obtained at a frequency of 20%) produced the same amount of streptomycin as the wild-type strain. This result indicates that the suppression of streptomycin production is due to amplification of the specific 0.7-kb DNA region from BamHI(1) to BamHI(2) (Fig.  6) .
Expression of streptomycin 6-phosphotransferase gene in E. coli. We expected that a structural gene of streptomycin 6-phosphotransferase might be located near the probable regulatory gene strR. To examine whether the cloned DNA carried the streptomycin 6-phosphotransferase gene, we studied expression in E. coli of streptomycin 6-phosphotransferase activity from the cloned DNA. The 7.4-kb BglII fragment of pADT4 was inserted into a BamHI site of pBR322 in two possible orientations, and the resulting plasmids were named pSMP2 and pSMP3 (Fig. 5 ). E. coli cells harboring pSMP2 or pSMP3 were resistant to ampicillin but sensitive to streptomycin; they could not grow on LB plates containing 20 ,ug of streptomycin per ml, and their cell extracts contained no streptomycin-inactivating activity.
When replica plated onto LB plates containing both ampicillin (35 ,ug/ml) and streptomycin (20 ,ug/ml), ampicillin-resistant colonies of E. coli carrying either pSMP2 or pSMP3 gave rise to streptomycin-resistant clones with a frequency of 0.7 or 0.02%, respectively. In control experiments, no streptomycin-resistant clone was obtained from E. coli carrying only vector plasmid pBR322. pSMP21 and pSMP31 were isolated from these streptomycin-resistant clones; pSMP21 was derived from pSMP2, while pSMP31 was derived from pSMP3. All ampicillinresistant colonies obtained after retransformation with each of the two plasmids could grow on LB plates containing 20 jig of streptomycin per ml, indicating that a streptomycin resistance gene was encoded on these plasmids. Restriction endonuclease cleavage maps of the streptomycin resistance plasmids were constructed. pSMP21 had a deletion of about 2.4 kb, losing the AatI(1) and EcoRI sites in the insert of pSMP2, whereas pSMP31 resulted from an inversion of about 4-kb segment encompassing the fragment from AatI (2) to ScaI(2) (Fig. 5 and 6 ).
Cell extracts of the transformants with pSMP21 or pSMP31 were capable of inactivating streptomycin, and the inactivated product was reversely activated by treatment with E. coli alkaline phosphatase (Fig. 7) . To confirm that 92 OHNUKI ET AL. Fig. 4 , whereas the pSMP plasmids were constructed in E. coli as shown in Fig. 5 . Restriction sites appearing more than once on the DNA insert of pADT4 are distinguished by the numbers in parentheses. Genes responsible for complementation of SM196, SD141, and SD245 were designated as strR, strB, and strC, respectively. A structural gene of streptomycin 6-phosphotransferase was designated as strA. Broken lines indicate the approximate location of the str genes. A set of crosses denotes the DNA region responsible for inhibition of streptomycin biosynthesis by pADT43 and pADT44, i.e., the 0.7-kb DNA fragment from BamHI(1) to BamHI(2). the streptomycin phosphotransferase in E. coli carrying pSMP21 or pSMP31 phosphorylated the streptidine moiety of streptomycin, we performed a radiochemical assay using streptidine and [32P]ATP as substrates. Both cell extracts gave a radioactive compound with an Rf of 0.4, which corresponds to that of streptidine 6-phosphate (33) , and their specific activities of streptomycin 6-phosphotransferase were about 4 U per mg of protein, regardless of the plasmids.
The results described thus far indicate that streptomycin 6-phosphotransferase is expressed from the DNA inserts of pSMP21 and pSMP31. Therefore, we conclude that a structural gene of streptomycin 6-phosphotransferase is cloned together with the other str genes, and we designate the gene as strA.
To localize the strA gene on the cloned DNA, derivative plasmids of pSMP21 were constructed as shown in Fig. 5 . pSMP211, which lacked the 2.1-kb Scal fragment of pSMP21, conferred streptomycin resistance to E. coli, whereas pSMP212, which lacked the 0.7-kb segment from BamHI(1) to BamHI(2), did not ( Fig. 5 and 6 ). Streptomycininactivating activity was detected in E. coli cells carrying pSMP211 but not in those carrying pSMP212. These results indicate that the strA gene is located on an approximately 2-kb DNA region from the left end of the DNA insert of pSMP211 to the ScaI(1) site, and that the 0.7-kb BamHI fragment contains an essential region of the strA gene (Fig.  6 ).
DISCUSSION
We cloned an str gene cluster including strR, strA, strB, and strC by using an S. griseus host-vector system. By deletion analysis, the order of the four genes was determined to be strR-strA-strB-strC (Fig. 6) .
The strA gene was verified to encode streptomycin 6-phosphotransferase by testing expression of the enzyme activity from the cloned DNA in E. coli. Bibb and Cohen (2) have reported that many, if not all, Streptomyces promoters cannot be recognized by E. coli RNA polymerase. In this study, the indigenous promoter of strA seems to be inert in E. coli, since E. coli cells carrying pSMP2 or pSMP3 expressed no streptomycin 6-phosphotransferase activity, despite the presence of the entire strA gene and the flanking regions on the plasmids. Only after deletion (resulting in pSMP21) or inversion (in pSMP31) was the detectable expression of strA recognized in E. coli. In these streptomycin resistance plasmids, the strA gene might be transcribed by readthrough from the P2 promoter for the tet gene on pBR322 (30) , judging from the orientation and location of strA to the promoter. Accordingly, it is inferred that the strA gene might be transcribed toward the right in Fig. 6 . Streptomycin 6-phosphotransferase genes of S. griseus HUT 6037 and Streptomyces glaucescens have been cloned in Streptomyces lividans (7, 27 The strR gene complemented the Str-Strs strain SM196 that suffered a mutation impairing both amidinotransferase and streptomycin 6-phosphotransferase activities, whereas the strB gene complemented the Str-strain SD141 specifically deficient in amidinotransferase. The strR+ strA strB plasmid (pADT412) did indeed restore the ability of SM196 to express both enzyme activities (Table 3) . It was also demonstrated by segregation of pADT412 that strR encoded a trans-acting gene product. The strR+ strA+ strB+ plasmids (pADT41 and pADT42) led to a high expression of amidinotransferase in the transformed cells (Table 3) . Based on these results, we conclude that the strB gene encodes amidinotransferase and that the strR gene encodes a positive effector required for the full expression of the strA and strB genes.
The strR gene was localized on the 3.3-kb DNA region from BglII(1) to BamHI(1) (Fig. 6) . The plasmids containing this region induced the overproduction of streptomycin in S. griseus ATCC 10137. It seems strange that the wild-type strain carrying the strR+ strB plasmids (pADT411 and pADT412) exhibited the enhanced streptomycin productivity, despite only a little increase of amidinotransferase activity (Table 3) . This fact could be explained by the assumption that the strR gene might positively control the expression of some other str genes in addition to the strA and strB genes. Another possible explanation is that the 3.3-kb region of DNA might carry an unidentified gene of a key enzyme for streptomycin biosynthesis, if it exists.
The strC gene was defined as a gene conferring the Str+ phenotype on SD245. The Str-strain SD245 had a defect in the linkage step J (Fig. 1) due to a change of substrate specificity of dihydrostreptosyltransferase, which catalyzes the reaction; the mutated enzyme in SD245 was altered to utilize streptidine but not streptidine 6-phosphate, a normal intermediate, as an acceptor (22) . Therefore, the strC gene probably encodes dihydrostreptosyltransferase. However, there is an alternative possibility that the strC gene may encode streptomycin 6-phosphohydrolase, which catalyzes reaction step M in Fig. 1 (33) ; if a structural gene for that enzyme were carried on a plasmid and the enzyme were substantially synthesized in the transformed cells, the streptidine 6-phosphate accumulated in SD245 would be dephosphorylated to streptidine, which could be converted to streptomycin by SD245 (22) . The gene product of strC deserves further biochemical studies with the transformant that carries an strC plasmid.
An interesting finding in this study was that amplification of the specific 0.7-kb DNA region on plasmids inhibited both streptomycin biosynthesis (enzymologically, amidinotransferase activity) and streptomycin resistance (streptomycin 6-phosphotransferase activity) ( Table 3 and Fig. 6) . A similar phenomenon has been reported in studies concerning spore formation in B. subtilis. Banner et al. (1) have discovered that propagation of the SpoVG promoter region on a high-copy-number plasmid interferes with the process of sporulation in B. subtilis and have proposed that the interference is due to titration of a sporulation-specific regulatory protein that binds at the promoter region. By analogy, the 0.7-kb fragment might titrate a gene product of strR; pADT43 inhibited streptomycin production of the transformed cells, whereas pADT41 did not. Therefore, the 0.7-kb region might carry a regulatory apparatus that participates in the control mediated by an strR gene product. Alternatively, the region might encode a toxic or a repressible substance that inhibits both streptomycin synthesis and streptomycin resistance when overproduced from the plasmids.
As described above, the streptomycin resistance gene (strA) and the streptomycin biosynthesis gene(s) share a common regulatory system directed by the strR gene. In addition to the strR system, the regulation of strA expression involves an induction system with streptomycin, which was demonstrated by a streptomycin 6-phosphotransferase assay with the Str-mutants (Table 2 ). This induction system might permit the continuance of strA expression in parallel with streptomycin accumulation even after the cessation of the expression of streptomycin biosynthesis genes.
Nucleotide sequencing and further analysis of regulatory sequences of the cloned str genes would provide a new insight on the regulatory mechanisms involved in streptomycin biosynthesis and streptomycin resistance at the molecular level.
In the course of shotgun cloning, the DNA segments that conferred on SD141 the ability to produce unidentified antibiotics were cloned in pADT1, pADT2, pADT3, pADT5, and pADT6. The other Str-mutants carrying each of these plasmids also produced the antibiotics. We suppose that amplification of the specific DNA regions might elicit the potential of S. griseus ATCC 10137 to produce some antibiotics other than streptomycin. Identification 
